Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice

BACKGROUND: Previously, we demonstrated the therapeutic efficacy of a human papillomavirus (HPV) vaccine, including HPV16 E7 peptide and CpG oligodeoxynucleotides (CpG ODN), against small TC-1 grafted tumors. Here, we developed an HPV16 E7 peptide and CpG ODN vaccine delivered using liposomes modifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yan, Wang, Huan, Yang, Yang, Jia, Wendan, Su, Tong, Che, Yuxin, Feng, Yixin, Yuan, Xuemei, Wang, Xuelian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718974/
https://www.ncbi.nlm.nih.gov/pubmed/33293808
http://dx.doi.org/10.2147/IJN.S275670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718974/
https://www.ncbi.nlm.nih.gov/pubmed/33293808
http://dx.doi.org/10.2147/IJN.S275670

Ejemplares similares